Esperion Therapeutics (ESPR) Sees Strong Upside on Volume

September 20, 2016 11:44 AM EDT
Get Alerts ESPR Hot Sheet
Trade ESPR Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Esperion Therapeutics (NASDAQ: ESPR) is seeing sharp upside on heavy volume. Shares are up 16.5% on volume that is 6x normal. Upside could be coming amid M&A activity/valuation in the biotech space, including today's Allergan plc (NYSE: AGN) deal for Tobira Therapeutics, Inc. (NASDAQ: TBRA) at premium of up to 1650%.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Momentum Movers, Trader Talk

Add Your Comment